Satellos Bioscience Inc. (MSLE) vs Tvardi Therapeutics, Inc. (TVRD)
A side-by-side comparison of Satellos Bioscience Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MSLE
Satellos Bioscience Inc.
$7.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVRD
Tvardi Therapeutics, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MSLE vs TVRD
growth of $100 · dividends reinvested · last 1yMSLE +13.7% (+13.7%/yr)TVRD -74.6% (-74.6%/yr)MSLE compounded faster over this window
MSLE TVRD
MSLE vs TVRD: by the numbers
- •TVRD is the larger company ($10M vs $10M market cap).
Metrics side by side
Valuation
| Metric | MSLE | TVRD |
|---|---|---|
| P/B ratio | 0.16 | 1.21 |
Profitability
| Metric | MSLE | TVRD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -57.34% | -310.94% |
| ROIC | -59.35% | -323.71% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.